We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Rabin Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00418119
First Posted: January 4, 2007
Last Update Posted: January 4, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rabin Medical Center
  Purpose
Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Condition Intervention Phase
Heart Failure Drug: erythropoietin Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Resource links provided by NLM:


Further study details as provided by Rabin Medical Center:

Estimated Enrollment: 10
Study Start Date: January 2007
Estimated Study Completion Date: January 2008
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ischemic heart disease
  • Systolic lv dysfunction
  • Mild anemia
  • Normal renal function
  • Stable condition

Exclusion Criteria:

  • Pregnancy
  • Unstable condition
  • Under 18 years old
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00418119


Contacts
Contact: Tuvia Ben Gal, MD 972-522757616 bengalt@clalit.org.il
Contact: Daniel Murninkas, MD 972-39376930 murninkasd@clalit.org.il

Locations
Israel
Cardiology Department, Rabin Medical Center Not yet recruiting
Petah Tikva, Israel, 49100
Contact: Tuvia Ben Gal, MD    972-522757616    bengalt@clalit.org.il   
Contact: Daniel Murninkas, MD    972-39736930    murninkasd@clalit.org.il   
Principal Investigator: Tuvia Ben Gal, MD         
Sub-Investigator: Ofer Shpilberg, Prof.         
Sub-Investigator: Daniel Murninkas, MD         
Sponsors and Collaborators
Rabin Medical Center
Investigators
Principal Investigator: Tuvia Ben Gal, MD Cardiology Department Rabin medical Center
Study Director: Ofer Shpilberg, Prof. Hematology Department Rabin Medical Center
Study Director: Daniel Murninkas, MD Cardiology Department Rabin Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00418119     History of Changes
Other Study ID Numbers: 4273
First Submitted: January 2, 2007
First Posted: January 4, 2007
Last Update Posted: January 4, 2007
Last Verified: December 2006

Additional relevant MeSH terms:
Heart Failure
Ventricular Dysfunction
Ventricular Dysfunction, Left
Heart Diseases
Cardiovascular Diseases
Epoetin Alfa
Hematinics